Literature DB >> 18984055

Refolding and kinetic characterization of the phosphodiesterase-8A catalytic domain.

Zier Yan1, Huanchen Wang, Jiwen Cai, Hengming Ke.   

Abstract

Cyclic nucleotide phosphodiesterase-8 (PDE8) hydrolyzes the second messenger cAMP and is involved in many biological processes such as testosterone production. Although the bacterial and mammalian expression systems have been extensively tried, production of large quantity of soluble and active PDE8 remains to be a major hurdle for pharmacological and structural studies. Reported here is a detailed protocol of refolding and purification of large quantity of the PDE8A1 catalytic domain (residues 480-820) and kinetic characterization of the refolded protein. This protocol yielded about 8 mg of the PDE8A catalytic domain from 2l Escherichia coli culture, which has at least 40-fold higher activity than those reported in literature. The PDE8A1 catalytic domain has k(cat) of 4.0 s(-1) for Mn(2+) and 2.9s(-1) for Mg(2+), and the K(M) values of 1-1.8 microM. In addition, the PDE8A1 (205-820) fragment that contains both PAS and catalytic domains was expressed in E. coli and refolded. This PDE8A1 (205-820) fragment has k(cat) of 1.1 s(-1) and K(M) of 0.28 microM, but aggregated at high concentration. The K(M) of PDE8A1 (205-820) is 2- to 7-fold higher than the K(M) values of 40-150 nM for the full-length PDE8s in literature, but about 6-fold lower than that of the catalytic domain. Thus, the K(M) difference likely implies an allosteric regulation of the PDE8A activity by its PAS domain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18984055      PMCID: PMC2677826          DOI: 10.1016/j.pep.2008.10.005

Source DB:  PubMed          Journal:  Protein Expr Purif        ISSN: 1046-5928            Impact factor:   1.650


  48 in total

1.  T cell activation up-regulates cyclic nucleotide phosphodiesterases 8A1 and 7A3.

Authors:  N A Glavas; C Ostenson; J B Schaefer; V Vasta; J A Beavo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  Comparison of enzymatic characterization and gene organization of cyclic nucleotide phosphodiesterase 8 family in humans.

Authors:  Michiko Gamanuma; Keizo Yuasa; Takashi Sasaki; Naoki Sakurai; Jun Kotera; Kenji Omori
Journal:  Cell Signal       Date:  2003-06       Impact factor: 4.315

3.  Human phosphodiesterase 8A splice variants: cloning, gene organization, and tissue distribution.

Authors:  P Wang; P Wu; R W Egan; M M Billah
Journal:  Gene       Date:  2001-12-12       Impact factor: 3.688

4.  Genomic organization, chromosomal localization, and alternative splicing of the human phosphodiesterase 8B gene.

Authors:  Masaaki Hayashi; Yasuhito Shimada; Yuhei Nishimura; Takaaki Hama; Toshio Tanaka
Journal:  Biochem Biophys Res Commun       Date:  2002-10-11       Impact factor: 3.575

5.  Atomic structure of PDE4: insights into phosphodiesterase mechanism and specificity.

Authors:  R X Xu; A M Hassell; D Vanderwall; M H Lambert; W D Holmes; M A Luther; W J Rocque; M V Milburn; Y Zhao; H Ke; R T Nolte
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

Review 6.  Molecular diversity of cyclic AMP signalling.

Authors:  F A Antoni
Journal:  Front Neuroendocrinol       Date:  2000-04       Impact factor: 8.606

Review 7.  Phosphodiesterase 5 inhibitors: current status and potential applications.

Authors:  David P Rotella
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

8.  Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization.

Authors:  S Pérez-Torres; R Cortés; M Tolnay; A Probst; J M Palacios; G Mengod
Journal:  Exp Neurol       Date:  2003-08       Impact factor: 5.330

Review 9.  The pharmacology of cilostazol.

Authors:  Karsten Schrör
Journal:  Diabetes Obes Metab       Date:  2002-03       Impact factor: 6.577

10.  Kinetic and structural studies of phosphodiesterase-8A and implication on the inhibitor selectivity.

Authors:  Huanchen Wang; Zier Yan; Serena Yang; Jiwen Cai; Howard Robinson; Hengming Ke
Journal:  Biochemistry       Date:  2008-12-02       Impact factor: 3.162

View more
  3 in total

1.  Channeling of cAMP in PDE-PKA Complexes Promotes Signal Adaptation.

Authors:  Nikhil Kumar Tulsian; Srinath Krishnamurthy; Ganesh Srinivasan Anand
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

2.  Structure-based discovery of orally efficient inhibitors via unique interactions with H-pocket of PDE8 for the treatment of vascular dementia.

Authors:  Xu-Nian Wu; Qian Zhou; Ya-Dan Huang; Xi Xie; Zhe Li; Yinuo Wu; Hai-Bin Luo
Journal:  Acta Pharm Sin B       Date:  2022-02-22       Impact factor: 14.903

3.  Active site coupling in PDE:PKA complexes promotes resetting of mammalian cAMP signaling.

Authors:  Srinath Krishnamurthy; Balakrishnan Shenbaga Moorthy; Lim Xin Xiang; Lim Xin Shan; Kavitha Bharatham; Nikhil Kumar Tulsian; Ivana Mihalek; Ganesh S Anand
Journal:  Biophys J       Date:  2014-09-16       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.